CSS
GH icon

Cubist Systematic Strategies’s Guardant Health GH Stock Holding History

Cubist Systematic Strategies’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$469K Buy
+7,500
New +$408K ﹤0.01% 2306
2024
Q1 		– Sell
-11,100
Closed -$300K – 3918
2023
Q4 		$300K Buy
11,100
+1,700
+18% +$44.6K ﹤0.01% 2790
2023
Q3 		$279K Buy
9,400
+300
+3% +$10.5K ﹤0.01% 2633
2023
Q2 		$326K Buy
+9,100
New +$261K ﹤0.01% 2598

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's GH Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Guardant Health (GH) in Q3 2025, closing a stake of 329,322 shares — an estimated $17.9M sold.

Cubist Systematic Strategies first reported a position in GH in Q1 2019 and held it in 21 quarters. The position peaked at $17.1M in Q2 2025. 395 funds tracked by Wall St. Rank hold GH as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Guardant Health position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 329,322 Guardant Health shares in Q3 2025, an estimated $17.9M.
  • Cubist Systematic Strategies first reported a position in Guardant Health in Q1 2019 and held it in 21 quarters.
  • Cubist Systematic Strategies's Guardant Health position peaked at $17.1M in Q2 2025.
  • 395 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.